In agreement with this, our previous studies allowed us to observe that the genetic suppression of CCL2 in the 5xFAD mouse model of Alzheimer’s disease reduces the accumulation of amyloid β plaques, the production of pro-inflammatory mediators and the neuronal damage [2]. The gene discussed is CCL2; the disease is Alzheimer disease.